Citation

Rageot D, Bohnacker T, Melone A, Langlois JB, Borsari C, Hillmann P, Sele AM, Beaufils F, Zvelebil M, Hebeisen P, Löscher W, Burke J, Fabbro D, Wymann MP.: Discovery and Preclinical Characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a Highly Potent and Selective mTORC1/2 Inhibitor for Cancer and Neurological Disorders. J Med Chem, Volume 61 (22), 2018

Authors

Beaufils F, Bohnacker T, Borsari C, Burke J, Fabbro D, Hebeisen P, Hillmann P, Langlois JB, Löscher W, Melone A, Rageot D, Sele AM, Wymann MP., Zvelebil M

Journal

J Med Chem

Year

2018

DOI

10.1021/acs.jmedchem.8b01262

PubMed

30359003

Machine-readable

REST APIRDF